Loading…
ClearPoint Neuro, Inc. is projected to rise to $23.94 by 2027, a +60% move from its current price of $14.94. CLPT is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean neutral.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 8/1/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Aug 3 | $14.48 | $14.95 | $15.43 | +0.06% |
| Aug 4 | $14.30 | $14.96 | $15.65 | +0.11% |
| Aug 5 | $14.16 | $14.97 | $15.82 | +0.17% |
| Aug 6 | $14.05 | $14.97 | $15.96 | +0.23% |
| Aug 7 | $13.95 | $14.98 | $16.09 | +0.28% |
| Aug 8 | $13.86 | $14.99 | $16.21 | +0.34% |
| Aug 9 | $13.78 | $15.00 | $16.32 | +0.39% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $13.78 | $15.00 | $16.32 | +0.39% |
| Week 2 | $13.36 | $15.06 | $16.97 | +0.79% |
| Week 3 | $13.06 | $15.12 | $17.50 | +1.19% |
| Week 4 | $12.81 | $15.18 | $17.97 | +1.59% |
| Week 5 | $12.61 | $15.24 | $18.41 | +1.99% |
| Week 6 | $12.43 | $15.30 | $18.82 | +2.39% |
| Week 7 | $12.28 | $15.36 | $19.21 | +2.80% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
ClearPoint Neuro, Inc. is a commercial-stage medical device company focused on platforms for performing minimally invasive brain procedures in the United States. Its offerings span hardware, disposables, software, and related services designed to support brain-surgery navigation and guidance.
The company’s product family includes ClearPoint hardware (head fixation frame, computer workstation, and in-room monitor), ClearPoint disposables (SmartFrame trajectory device, a hand controller and related accessories, and its SmartFlow Neuro cannula), and ClearPoint software that guides planning, device alignment, navigation to the target, and procedure monitoring. It also offers ClearPoint Prism Neuro laser therapy system to necrotize or coagulate soft tissue, and the IRRAflow system, an active fluid exchange platform. In addition, the company provides consulting services to pharmaceutical and other medical technology partners, including benchtop testing, preclinical studies, clinical trial support, regulatory consultation, and translation from the preclinical to the clinical setting.
ClearPoint Neuro, Inc. (CLPT) trades at $14.49 per share and has a market capitalization of $434.55M, ranking 3081. The stock’s current price and market cap place it in the lower tier by size among public equities.
The 2026 forecast shows a flat start relative to today, with an average price of $14.49 and a range from $8.66 to $20.68, suggesting limited upside in the near term. Over the longer horizon, the model projects a bullish path, with the average price rising to $22.70 by 2027, $33.51 by 2030, and ultimately $198.61 by 2050. The implied upside is substantial through 2050, with a maximum forecast price of $408.93.
A major floor 42.0% below — a decisive break under it would weaken the trend.
The nearest floor, 5.5% below — buyers have tended to step in here.
The nearest ceiling, 30.1% above — a clean break opens room to run.
A major ceiling 43.7% above — clearing it would confirm fresh momentum.
Key CLPT support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of CLPT market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $14.56 | Buy | $14.65 | Buy |
| MA 10 | $14.69 | Buy | $14.85 | Buy |
| MA 20 | $15.67 | Sell | $15.29 | Sell |
| MA 50 | $15.11 | Sell | $14.93 | Buy |
| MA 100 | $12.85 | Buy | $14.15 | Buy |
| MA 200 | $14.22 | Buy | $13.82 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 46.58 | Neutral |
| Stoch RSI (14) | 87.11 | Sell |
| CCI (20) | -44.48 | Neutral |
| Williams %R (14) | -55.43 | Info |
| MACD (12,26,9) | -0.20 | Sell |
| ROC (12) | -4.66 | Sell |
| Bollinger %B (20,2) | 0.36 | Neutral |
| Stochastic %K (14) | 44.57 | Neutral |
| TRIX (15) | -0.17 | Sell |
| Awesome (5,34) | -1.71 | Sell |
| Ultimate (7,14,28) | 43.52 | Neutral |
| Momentum (10) | -0.21 | Sell |
| Aroon Osc (25) | -72.00 | Sell |
| Hull MA (9) | 14.49 | Buy |
| ADX (14) | 17.61 | Neutral |
| ATR (14) | 0.46 | Info |
Technical sentiment is NEUTRAL with RSI(14) at 40. The stock trades around the 50-day simple moving average of $14.81 and the 200-day simple moving average of $14.61. Key near-term levels include a support at $13.34 and a resistance at $19.43. The 30-day price range spans from a low of $11.45 to a high of $18.33.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $8.66 | $14.94 | $21.50 | 0% | Neutral | |
| $18.80 | $23.94 | $32.42 | +60% | Bullish | |
| $22.10 | $29.12 | $41.16 | +95% | Bullish | |
| $23.77 | $32.19 | $47.04 | +115% | Bullish | |
| $27.61 | $38.35 | $57.61 | +157% | Bullish | |
| $29.34 | $41.67 | $64.14 | +179% | Bullish | |
| $32.19 | $46.69 | $73.44 | +213% | Bullish | |
| $41.70 | $61.70 | $98.95 | +313% | Bullish | |
| $50.72 | $76.48 | $124.87 | +412% | Bullish | |
| $55.81 | $85.70 | $142.27 | +474% | Bullish | |
| $85.58 | $142.81 | $254.02 | +856% | Bullish | |
| $150.03 | $289.77 | $569.45 | +18.4x | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| August 2026 | $8.66 | $14.94 | $18.23 | +0.00% |
| September 2026 | $12.58 | $14.96 | $18.34 | +0.11% |
| October 2026 | $13.12 | $15.73 | $19.53 | +5.15% |
| November 2026 | $13.90 | $16.77 | $21.03 | +6.65% |
| December 2026 | $14.00 | $16.99 | $21.50 | +1.28% |
Click any year to see its month-by-month CLPT forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
By 2026, CLPT could reach as high as $21.50, with a base case around $14.94 and support toward $8.66 — roughly 0% from $14.94. Price action looks broadly range-bound.
Expect CLPT to range from $18.80 to $32.42 through 2027. The $23.94 average target implies a +60% move from current prices. That is up +60% on the projected 2026 average. Buyers look set to stay in control over this stretch.
The CLPT price prediction for 2028 points to an average of $29.12 (low $22.10, high $41.16) — a potential gain of +95% on today's $14.94. Momentum favours further upside here.
In 2029, CLPT is projected to trade between $23.77 and $47.04, averaging $32.19 — a potential gain of +115% from today's $14.94. That is up +11% on the projected 2028 average. Buyers look set to stay in control over this stretch.
ClearPoint Neuro, Inc.'s 2030 outlook centres on $38.35, within a $27.61 to $57.61 range. That is up +19% on the projected 2029 average. That marks a +157% change versus current levels. Momentum favours further upside here.
By 2031, CLPT could reach as high as $64.14, with a base case around $41.67 and support toward $29.34 — roughly +179% from $14.94. Buyers look set to stay in control over this stretch.
Expect CLPT to range from $32.19 to $73.44 through 2032. The $46.69 average target implies a +213% move from current prices. That is up +12% on the projected 2031 average. Momentum favours further upside here.
The CLPT price prediction for 2033 points to an average of $61.70 (low $41.70, high $98.95) — a potential gain of +313% on today's $14.94. Buyers look set to stay in control over this stretch.
In 2034, CLPT is projected to trade between $50.72 and $124.87, averaging $76.48 — a potential gain of +412% from today's $14.94. That is up +24% on the projected 2033 average. Momentum favours further upside here.
ClearPoint Neuro, Inc.'s 2035 outlook centres on $85.70, within a $55.81 to $142.27 range. That is up +12% on the projected 2034 average. That marks a +474% change versus current levels. Buyers look set to stay in control over this stretch.
By 2040, CLPT could reach as high as $254.02, with a base case around $142.81 and support toward $85.58 — roughly +856% from $14.94. Momentum favours further upside here.
Expect CLPT to range from $150.03 to $569.45 through 2050. The $289.77 average target implies a +18.4x move from current prices. That is up +103% on the projected 2040 average. Buyers look set to stay in control over this stretch.
Investing $1,000 in CLPT today (≈ 66.934404 CLPT) could be worth
$19,395.78
+$18,395.78 (+1840%) by 2050 · US Dollar
Based on the average projected CLPT price of $289.77 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in CLPTwould be worth at today's price.
$1,000 invested in CLPT on Jul 31, 2025 (≈ 96.15385 CLPT) would be worth
$1,436.54
+$436.54 (+43.7%) today · 1.44× · US Dollar
Based on a CLPT entry price of $10.4 vs. today's $14.94.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $14.12 | $1,058.07 | +5.8% |
| 1 month ago | $18.72 | $798.08 | -20.2% |
| 3 months ago | $11.37 | $1,313.98 | +31.4% |
| 6 months ago | $13.24 | $1,128.4 | +12.8% |
| 1 year ago | $10.4 | $1,436.54 | +43.7% |
| All time (5.0y) ago | $20.23 | $738.51 | -26.1% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our CLPT forecast.
Our base-case forecast reaches $30.00 around 2029.
Implied market cap at $30.00: $899.69M
The multi-year forecast shows a bullish trajectory: the average price is projected to rise from $14.49 in 2026 to $22.70 in 2027, $26.94 in 2028, $28.41 in 2029, and $33.51 in 2030, with an ROI of 131.3% by 2030. By 2040, the average forecast price is $103.36, with a range from $58.67 to $191.31 and an ROI of 613.3%. By 2050, the average forecast price is $198.61, with a range from $94.68 to $408.93 and an ROI of 1270.7%.
The sentiment remains BULLISH across the later years. These are estimates, not guarantees, and actual outcomes may differ.
Tap a question to reveal the answer.
The 2030 forecast shows an average price of $33.51, with a min of $23.53 and a max of $51.71, corresponding to an ROI of 131.3% and a bullish sentiment.
Forecasts indicate bullish sentiment from 2027 onward, with the average price rising to $22.70 in 2027, $33.51 in 2030, and $198.61 in 2050, and ROI up to 1270.7% by 2050, though these are estimates and not guarantees.
Yes, the 2040 forecast shows an average price of $103.36, with a min of $58.67 and a max of $191.31, implying potential to reach around $100 within the forecast horizon.
The 30-day range is $11.45 to $18.33.
The current price is $14.49 and the market cap is $434.55M.
ClearPoint Neuro, Inc. Community Discussion
0Share your ClearPoint Neuro, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.